Evidence map›Paper›PMID 31018590›Full record

ReviewInternational journal of molecular sciences2019

Pigment Nephropathy: Novel Insights into Inflammasome-Mediated Pathogenesis.

Kurt T K Giuliani, Andrew J Kassianos, Helen Healy, Pedro H F Gois

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Interleukin-10 attenuates renal injury after myocardial infarction in diabetes.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2022
    Article
  6. Article
  7. Article
  8. Kidney Inflammation, Injury and Regeneration.International journal of molecular sciences · 2020
    Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kurt T K GiulianiKidney Health Service, Royal Brisbane and Women's Hospital, Brisbane, QLD 4029, Australia. Kurt.Giuliani@uqconnect.edu.au.ORCID 0000-0001-5454-8483
Andrew J KassianosKidney Health Service, Royal Brisbane and Women's Hospital, Brisbane, QLD 4029, Australia. Andrew.Kassianos@qimrberghofer.edu.au.
Helen HealyKidney Health Service, Royal Brisbane and Women's Hospital, Brisbane, QLD 4029, Australia. Helen.Healy@health.qld.gov.au.ORCID 0000-0003-4342-5300
Pedro H F GoisKidney Health Service, Royal Brisbane and Women's Hospital, Brisbane, QLD 4029, Australia. Pedro.FrancaGois@health.qld.gov.au.
The University of Queensland · AUQueensland University of Technology · AU

Funding

National Health and Medical Research Council GNT1099222
6 · The paper itself

Abstract

Pigment nephropathy is an acute decline in renal function following the deposition of endogenous haem-containing proteins in the kidneys. Haem pigments such as myoglobin and haemoglobin are filtered by glomeruli and absorbed by the proximal tubules. They cause renal vasoconstriction, tubular obstruction, increased oxidative stress and inflammation. Haem is associated with inflammation in sterile and infectious conditions, contributing to the pathogenesis of many disorders such as rhabdomyolysis and haemolytic diseases. In fact, haem appears to be a signalling molecule that is able to activate the inflammasome pathway. Recent studies highlight a pathogenic function for haem in triggering inflammatory responses through the activation of the nucleotide-binding domain-like receptor protein 3 (NLRP3) inflammasome. Among the inflammasome multiprotein complexes, the NLRP3 inflammasome has been the most widely characterized as a trigger of inflammatory caspases and the maturation of interleukin-18 and -1β. In the present review, we discuss the latest evidence on the importance of inflammasome-mediated inflammation in pigment nephropathy. Finally, we highlight the potential role of inflammasome inhibitors in the prophylaxis and treatment of pigment nephropathy.

Indexed as

AnimalsDiabetic NephropathiesHemeHemoglobinsHumansInflammasomesInflammationKidneyKidney DiseasesModels, MolecularMyoglobinNLR Family, Pyrin Domain-Containing 3 ProteinHemeHemoglobinsInflammasomesMyoglobinNLR Family, Pyrin Domain-Containing 3 Proteinacute kidney injuryhaemNLRP3 inflammasomepigment nephropathyrhabdomyolysis

Identifiers

PMID31018590
PMCPMC6514712
OpenAlexW2938468941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.